Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Better efficiency for microbial testing
June 2020
SHARING OPTIONS:

SOUTH SAN FRANCISCO, Calif. & HINXTON, U.K.—Fluidigm Corporation and Next Gen Diagnostics (NGD) have an exclusive agreement underway that provides NGD with access to the Fluidigm Juno system for pathogen whole-genome sequencing sample preparation. Per the agreement, Fluidigm will receive milestone payments in return beginning this year, as well as additional revenue over five years.
 
“Our partnership with Fluidigm will allow NGD to offer low-cost and high-throughput WGS for widespread use in hospitals,” said Dr. Paul A. Rhodes, founder and CEO of NGD. “By combining the cost reductions enabled by NGD’s full bioinformatic automation with the Juno microfluidic sample preparation system, we can offer hospitals and public health laboratories the power of WGS at unprecedentedly low cost, enabling detection of pathogen transmission and surveillance of the spread of drug-resistant pathogens.”

Back



PAGE UTILITIES


CONTACT US
DDNEWS
1000 N West Street, Suite 1200,
Wilmington, Delaware, 19801
Ph: 888-781-0328 |  Fax: 705-528-0270
 
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.